Literature DB >> 6391763

African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages.

J Fierer, J A Salmon, B A Askonas.   

Abstract

Many factors contribute to the severe immunosuppression associated with African trypanosomiasis. Macrophages have been shown to be important target cells which after uptake of parasites, mediate immune dysfunction in vivo. We observed that infection of mice with Trypanosome brucei brucei (clone NIM 6) induces profound changes in arachidonic acid metabolism and prostaglandin (PG) secretion by macrophages. Normal macrophages release more PGI2 than PGE2 and production of both these prostaglandins is stimulated equally by endotoxin (LPS). Macrophages taken from NIM 6 infected mice at the peak of the first parasitaemia, release increased amounts of PGE2 and are hyperresponsive to LPS stimulation, while PGI2 secretion remains normal. As the infection progresses, there is a striking decrease in both basal PGE2 and PGI2 secretion and the ability of macrophages to respond to LPS. By the third week of infection, shortly before death, peritoneal macrophages resemble thioglycollate elicited macrophages in their inability to be stimulated by LPS to synthesize prostaglandins. Infection with a more virulent clone of T. brucei (NIM9) results in suppression of both PGE2 and PGI2 release by day 9 of infection. The increased production of PGE2 by macrophages during the height of infection is likely to contribute to the general immunosuppression associated with African trypanosomiasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391763      PMCID: PMC1577105     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis.

Authors:  K M Hudson; C Byner; J Freeman; R J Terry
Journal:  Nature       Date:  1976-11-18       Impact factor: 49.962

2.  The measurement of proliferation in tissue cultures by enumeration of cell nuclei.

Authors:  K K SANFORD; W R EARLE; V J EVANS; H K WALTZ; J E SHANNON
Journal:  J Natl Cancer Inst       Date:  1951-02       Impact factor: 13.506

3.  Prostaglandins, aspirin-like drugs and the oedema of inflammation.

Authors:  S Moncada; S H Ferreira; J R Vane
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

4.  Immunosuppression during trypanosomiasis.

Authors:  L G Goodwin; D G Green; M W Guy; A Voller
Journal:  Br J Exp Pathol       Date:  1972-02

5.  Kinin release and the immune reaction in human trypanosomiasis caused by Trypanosoma rhodesiense.

Authors:  P F Boreham
Journal:  Trans R Soc Trop Med Hyg       Date:  1970       Impact factor: 2.184

6.  Macrophages synthesis and release prostaglandins in response to inflammatory stimuli.

Authors:  J L Humes; R J Bonney; L Pelus; M E Dahlgren; S J Sadowski; F A Kuehl; P Davies
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

7.  Suppressor cells and loss of B-cell potential in mice infected with Trypanosoma brucei.

Authors:  A C Corsini; C Clayton; B A Askonas; B M Ogilvie
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

8.  A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.

Authors:  S Moncada; R J Gryglewski; S Bunting; J R Vane
Journal:  Prostaglandins       Date:  1976-11

9.  Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes.

Authors:  J A Salmon; D R Smith; R J Flower; S Moncada; J R Vane
Journal:  Biochim Biophys Acta       Date:  1978-03-14

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  10 in total

1.  In vitro simulation of immunosuppression caused by Trypanosoma brucei.

Authors:  M Sileghem; A Darji; P De Baetselier
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

2.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense.

Authors:  M Oka; Y Ito
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Entamoeba histolytica alters arachidonic acid metabolism in macrophages in vitro and in vivo.

Authors:  W Wang; K Chadee
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

5.  Prostanoids during acute sarcocystiosis in growing pigs.

Authors:  A Daugschies; M Rommel; H O Hoppen
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

6.  Production of prostaglandins D2 and E2 by mouse fibroblasts and astrocytes in culture caused by Trypanosoma brucei brucei products and endotoxin.

Authors:  R A Alafiatayo; M R Cookson; V W Pentreath
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

Review 7.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major.

Authors:  E Cillari; F Y Liew; R Lelchuk
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

9.  Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon.

Authors:  A Darji; M Sileghem; H Heremans; L Brys; P De Baetselier
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections.

Authors:  Rita L Cardoni; María Inés Antúnez
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.